中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 4
Apr.  2011
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2011  >  27(4): 346-347+364

Comparison of diagnostic and treatment algorithm of America, Asia-Pacific and China for hepatocellular carcinoma

  • Received Date: 2011-01-18
  • Published Date: 2011-04-20
    Abstract
  • Primary hepatocellular carcinoma is the one of most common cancer worldwide, and diagnostic and treatment algorithms varies in different regions.American, Asian Pacific, and Chinese associations for the study of the liver have published their hepatocellular carcinoma expert consensus independently.In this article, we will analyze the difference and significance of the consensus by comparing of those three algorithms.

     

    • FullText(HTML)
  • loading
    • References(9)
  • [1]Tang ZY, Ye SL, Liu YK, et al.A decade's studies on metastasisof hepatocellular carcinoma[J].J Cancer Res Clin Oncol, 2004, 130 (4) :187-196.
    [2]Bruix J, Sherman M.Management of hepatocellular carcinoma:AnUpdate.Practice Guidelines Committee, American Association forthe Study of Liver Diseases[DB/OL].2010, http://www.aasld.org.
    [3]Bruix J, Sherman M.Management of hepatocellular carcinoma.Practice guidelines committee, American association for the studyof liver diseases[J].Hepatology, 2005, 42 (5) :1208-1236.
    [4]Omata M, Lesmana LA, Tateishi R, et al.Asian pacific associationfor the study of the liver consensus recommendations onhepatocellular carcinoma[J].Hepatol Int, 2010, 4 (2) :439-474.
    [5]中国抗癌协会肝癌专业委员会, 中国抗癌协会临床肿瘤学协作委员会, 中华医学会肝病学分会肝癌学组.原发性肝癌规范化诊治专家共识[J].临床肿瘤学杂志, 2009, 14 (3) :259-269
    [6]Breedis C, Young G.The blood supply of neoplasm in theliver[J].Am J Pathol, 1954, 30 (5) :969-977.
    [7]樊嘉, 周俭, 徐泱, 等.肝癌肝移植适应证的选择:上海复旦标准[J].中华医学杂志, 2006, 86 (18) :1227-1231.
    [8] Zheng SS, Xu X, Wu J, et al.Liver transplantation forhepatocellular carcinoma:Hangzhou experiences[J].Transplantation, 2008, 85 (12) :1726-1732.
    [9]Printz C.Clinical trials of note.Sorafenib as adjuvanttreatment in the prevention of disease recurrence in patientswith hepatocellular carcinoma (HCC) (STORM) [J].Cancer, 2009, 115 (20) :4646.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (4158) PDF downloads(1685) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return